16:39 EST Reviva Pharmaceuticals files $200M mixed securities shelf
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on RVPH:
- Reviva Pharmaceuticals to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference
- Reviva Pharmaceuticals provides program updates, upcoming milestones
- Karuna downgraded, Arm target raised: Wall Street’s top analyst calls
- Reviva may be most undervalued in neurology, says H.C. Wainwright
- Karuna Therapeutics downgraded to Neutral from Buy at H.C. Wainwright